IL113926A - Contrast medium with improved patient's tolerance thereto and its use - Google Patents

Contrast medium with improved patient's tolerance thereto and its use

Info

Publication number
IL113926A
IL113926A IL11392695A IL11392695A IL113926A IL 113926 A IL113926 A IL 113926A IL 11392695 A IL11392695 A IL 11392695A IL 11392695 A IL11392695 A IL 11392695A IL 113926 A IL113926 A IL 113926A
Authority
IL
Israel
Prior art keywords
tolerance
contrast medium
improved patient
patient
improved
Prior art date
Application number
IL11392695A
Other versions
IL113926A0 (en
Original Assignee
Korenstein Rafi
Dascalu Avi
Harel Avikam
Israel Humanitarian Foundation
Jade Holding Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korenstein Rafi, Dascalu Avi, Harel Avikam, Israel Humanitarian Foundation, Jade Holding Inc filed Critical Korenstein Rafi
Priority to IL11392695A priority Critical patent/IL113926A/en
Publication of IL113926A0 publication Critical patent/IL113926A0/en
Priority to AU59309/96A priority patent/AU707118B2/en
Priority to CA002222429A priority patent/CA2222429A1/en
Priority to EP96916620A priority patent/EP0863770A4/en
Priority to US08/952,954 priority patent/US6149891A/en
Priority to PCT/US1996/007666 priority patent/WO1996038183A1/en
Publication of IL113926A publication Critical patent/IL113926A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452—Solutions, e.g. for injection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL11392695A 1995-05-31 1995-05-31 Contrast medium with improved patient's tolerance thereto and its use IL113926A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IL11392695A IL113926A (en) 1995-05-31 1995-05-31 Contrast medium with improved patient's tolerance thereto and its use
AU59309/96A AU707118B2 (en) 1995-05-31 1996-05-24 Contrast medium and its use
CA002222429A CA2222429A1 (en) 1995-05-31 1996-05-24 Contrast medium and its use
EP96916620A EP0863770A4 (en) 1995-05-31 1996-05-24 Contrast medium and its use
US08/952,954 US6149891A (en) 1995-05-31 1996-05-24 X-ray contrast medium and method for protecting against harmful effects thereof
PCT/US1996/007666 WO1996038183A1 (en) 1995-05-31 1996-05-24 Contrast medium and its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11392695A IL113926A (en) 1995-05-31 1995-05-31 Contrast medium with improved patient's tolerance thereto and its use

Publications (2)

Publication Number Publication Date
IL113926A0 IL113926A0 (en) 1995-08-31
IL113926A true IL113926A (en) 2000-06-01

Family

ID=11067540

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11392695A IL113926A (en) 1995-05-31 1995-05-31 Contrast medium with improved patient's tolerance thereto and its use

Country Status (5)

Country Link
EP (1) EP0863770A4 (en)
AU (1) AU707118B2 (en)
CA (1) CA2222429A1 (en)
IL (1) IL113926A (en)
WO (1) WO1996038183A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10115740A1 (en) 2001-03-26 2002-10-02 Ulrich Speck Preparation for restenosis prophylaxis
DE10244847A1 (en) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medical device for drug delivery

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2191118A (en) * 1937-06-03 1940-02-20 Firm Of N V Orgachemia Pyelographic preparation
US2870063A (en) * 1955-07-05 1959-01-20 Mallinckrodt Chemical Works X-ray contrast composition comprising substantially amylose-free amylopectin in aqueous solution of contrast agent
US3984571A (en) * 1970-03-10 1976-10-05 E. R. Squibb & Sons, Inc. Hydrocolloid containing liquid carrier for a diagnostic or therapeutic agent
US5847009A (en) * 1986-01-14 1998-12-08 Alliance Pharmaceutical Corp. Prophylaxis in the parenteral administration of particulate dispersions in fluorocarbon emulsions
USRE34077E (en) * 1988-05-02 1992-09-22 Cryomedical Sciences, Inc. Blood substitute
FR2635327B1 (en) * 1988-08-10 1990-11-16 Guerbet Sa IODINE POLYMERS WITH DEXTRAN SKELETON, METHODS OF PREPARING THEM AND APPLICATIONS THEREOF AS CONTRAST PRODUCTS
US5019370A (en) * 1989-07-10 1991-05-28 University Of Kentucky Research Foundation Biodegradable, low biological toxicity radiographic contrast medium and method of x-ray imaging
US5199951A (en) * 1990-05-17 1993-04-06 Wayne State University Method of drug application in a transporting medium to an arterial wall injured during angioplasty
US5334370A (en) * 1993-02-04 1994-08-02 Sterling Winthrop Inc. Compositions of alkylbenzenes in film-forming materials for visualization of the gastrointestinal tract
DE19518221A1 (en) * 1995-05-10 1996-11-14 Schering Ag Use of non-steroidal anti-inflammatories to improve the physiological tolerance of particulate pharmaceutical preparations

Also Published As

Publication number Publication date
WO1996038183A1 (en) 1996-12-05
EP0863770A1 (en) 1998-09-16
AU707118B2 (en) 1999-07-01
AU5930996A (en) 1996-12-18
EP0863770A4 (en) 2001-01-10
CA2222429A1 (en) 1996-12-05
IL113926A0 (en) 1995-08-31

Similar Documents

Publication Publication Date Title
IL117859A0 (en) Isothiazolones and their uses
AU5772196A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
ZA966494B (en) New drugs and their use
AU5772296A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
IL118442A0 (en) Triazolymethyl-cyclopentanols their preparation and use
AU5772396A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
IL118441A0 (en) Triazolymethyl-oxiranes their preparation and use
IL106037A0 (en) Therapeutic and diagnostic methods based on neurotrophin-4-expression
GB9414157D0 (en) Medical use
IL114305A0 (en) 2,4,6-triiodo-5-substituted-amino-isophthalate esters and their use
EP0706396A4 (en) 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and use
AU3634595A (en) Bis-oxazolidines and their use
GB9514816D0 (en) Substances and their medical use
IL116014A0 (en) Iminooxymethyleneanilides their preparation and their use
EP0744125A3 (en) Iodo-complex and its use
IL113926A (en) Contrast medium with improved patient's tolerance thereto and its use
IL118444A0 (en) Mercapto-triazolyl-silanes their preparation and use
IL122686A0 (en) Benzylhydroxylamines their preparation and use
NZ323282A (en) N,n'-bridged bisindolylmaleimides and their use to prepare n,n'-bridged bisindolylmaleimides
EP0815219A4 (en) Human b-cell translocation genes-2 and 3
GB2290232B (en) Body and back support
AU7364596A (en) Human b-cell translocation genes-2 and 3
GB9714038D0 (en) Patients's chart
ZA963998B (en) 3,4-Disubstituted-phenylsulphonamides and their therapeutic use
ZA964001B (en) 3,4-Disubstituted-phenylsulphonamides and their therapeutic use

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees